In This Article:
Pfizer (PFE)
Pharmaceuticals giant Pfizer closed Tuesday's session nearly 5% in the green, after it issued an upbeat full-year outlook for 2025.
Pfizer guided to 2025 revenue of between $61bn (£48bn) and $64bn, along with adjusted earnings per share of $2.80 to $3 next year, both of which were in line with expectations.
Read more: FTSE 100 LIVE: Markets higher as UK inflation bump points to Bank of England interest rate hold
The drugmaker also reiterated its 2024 full-year guidance, estimating earnings per share of between $2.75 and $2.95.
Pfizer said it had also delivered on its goal of $4bn in net operating expense savings through 2024, with a further $500m in savings expected to come in 2025.
Dr. Albert Bourla, CEO of Pfizer, said: "Additionally, in support of our ongoing efforts to improve gross margin performance, we will work to make additional progress with our manufacturing optimization program in the coming year."
Micron Technology (MU)
US chipmaker Micron is due to report first-quarter results on Wednesday, with it having forecasted revenue of $8.7bn, which was ahead of the $8.3bn forecast by analysts.
Micron logged revenue of $25.1bn in its full-year results, released at the end of September, which was up from $15.5bn in the previous year.
Shares jumped after the release of its last set of results, though the stock has been volatile this year, leaving it 27% in the green year-to-date.
Read more: Pound, gold and oil prices in focus: commodity and currency check, 18 December
Last week, it was confirmed that AI chipmaker Micron had secured a $6.1bn subsidy from the US Department of Commerce for the build-out of semiconductor manufacturing plants within the US.
In a statement, the Department of Commerce said the funding would support Micron's two-decade plans to invest around $100bn in New York and $25bn in Idaho, which will create approximately 20,000 jobs.
The department said this would help the US grow its share of advanced memory manufacturing from less than 2% currently to around 10% by 2035.
These efforts to invest in chipmaking domestically come as trade tensions in this space intensify between the US and China.
Nissan (7201.T)
Shares in carmaker Nissan jumped 24% following reports that it was set to start merger talks with Honda (HMC).
According to a report from Nikkei Asia, the two carmakers are planning to begin talks with the hope of joining their resources amid increasing competition in the electric vehicle (EV) space.
The carmakers are considering operating under a holding company and may look for an eventual three-way tie-up with Mitsubishi (8058.T), the report said.